Melatonin add on anti epileptic drug
Phase 3
- Conditions
- seizure.Epilepsy and recurrent seizures
- Registration Number
- IRCT20101209005352N4
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age range 18_45 years
1_4 general idiopathic tonic-clonic seizure attacks in the last 4 months
Patients with a therapeutic level anti epileptic drugs
Exclusion Criteria
Patient dissatisfaction
Patients are intubation
Loss of consciousness
Patients without a therapeutic level anti epileptic drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency and severity of seizures. Timepoint: After 8 and 18 weeks of treatment. Method of measurement: According to Chalfont questionnaire.
- Secondary Outcome Measures
Name Time Method